Skip to content

RNAZ TRANSCODE THERAPEUTICS INC

Follow

COM NEW 2025 (common), issuer CIK 1829635

7 managers (8 13F filers) reported a position in RNAZ shares at 2026-06-30, 33,504 shares in all. 2 filers opened a position and 2 filers sold out during the quarter.

Managers
7
13F filers
8
New
2
Added
1
Reduced
1
Sold out
2
Shares held by filers
33,504

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q2 2026

Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Yorkville Advisors Global, LP19,639$122K0.14%new13F-HRTimeline
VANGUARD GROUP INCgroup of 2 filers holding9,527$59.2K0Timeline
UBS Group AGin group UBS Group AG2,888$17.9K<0.01%-5,40713F-HRTimelineGroup
FMR LLCin group FMR LLC706$4.38K<0.01%new13F-HRTimelineGroup
Tower Research Capital LLC (TRC)in group Tower Research Capital LLC (T…677$4.2K<0.01%+44913F-HRTimelineGroup
WELLS FARGO & COMPANY/MNin group WELLS FARGO & COMPANY/MN55$342<0.01%013F-HRTimelineGroup
SBI Securities Co., Ltd.12$75<0.01%013F-HRTimeline